Zhi-Cheng Xiao received his Doctor of natural science degree from Swiss Federal Institute of Technology, Zurich. He was also trained in Harbin Medical University, University of Science and Technology in China, and Beijing Medical University as a medical student and MSc and PhD candidate. He was a postdoctoral fellow of University of California, Irvine, University of Southern California, University of Rochester in USA, McGill University in Canada, and University Hamburg in Germany. He joined Singapore General Hospital in 2000 as a principal investigator, IMCB, Singapore in 2004, and Hong Kong University in 2008 as an Associate Professor. He joined GSK in 2009 as a Director of Innovative Research and currently working as a full Professor in Monash University. He published 74 articles, 5 chapters in books and also has 6 patents.
To understand the molecular events that mediate communication among neural cells in the nervous system during development, myelination, learning and memory, degeneration, and regeneration. These studies have yielded insights into the therapeutic potential of cell signalling molecules to ameliorate or even ablate the detrimental consequences of nervous system injury and neurodegenerative diseases, including stroke, traumatic brain injury, spinal cord injury, Alzheimer Disease (AD), and Multiple Sclerosis (MS)